1. AB0416 Reliability and Safety of A Novel Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus (SLE). (15th July 2016) Authors: Sheikh, S.Z.; Fox, N.L.; Hammer, A.E.; Struemper, H.; Groark, J.; Roth, D.; Gordon, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0305 Pharmacokinetics of Switching from Intravenous To Subcutaneous Belimumab for Patients with Systemic Lupus Erythematosus (SLE). (15th July 2016) Authors: Sheikh, S.Z.; Fox, N.L.; Hammer, A.E.; Struemper, H.; Groark, J.; Roth, D.; Gordon, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0403 A Randomised, Open-Label Study to Evaluate the Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector. (9th June 2015) Authors: Struemper, H.; Murtaugh, T.; Gilbert, J.; Barton, M.E.; Fire, J.; Groark, J.; Fox, N.L.; Roth, D.; Gordon, D. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗